المؤلفون: Sobia Tabassum

المصدر: Frontiers in Cell and Developmental Biology, Vol 11 (2023)

مصطلحات موضوعية: PROTACs (proteolysis targeting chimeras), cancer therapy, targeted drug, technolody development, technology innovation, Biology (General), QH301-705.5

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcell.2023.1131638/full; https://doaj.org/toc/2296-634X

URL الوصول: https://doaj.org/article/dd3e3eaf12234b3ca761d98810ab97ca

المؤلفون: Yamit Shorer Arbel, Ben-Zion Katz, Ronen Gabizon, Amit Shraga, Yotam Bronstein, Talia Kamdjou, Anat Globerson Levin, Chava Perry, Irit Avivi, Nir London, Yair Herishanu

المصدر: Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: PROTACs (proteolysis targeting chimeras), BTK - Bruton’s tyrosine kinase, CLL (Chronic Lymphocytic Leukemia), ibrutinib, BCR (B cell receptor) signaling, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.646971/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/650b70fb17db4836a1e4c93f379c112c

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tingting Chen, Ancheng Shen, Ao Zhang, Chunyong Ding, Zilan Song

المصدر: Acta Pharmaceutica Sinica B, Vol 10, Iss 12, Pp 2272-2298 (2020)
Acta Pharmaceutica Sinica. B

مصطلحات موضوعية: PD-L1, programmed death ligand 1, TBK1, medicine.medical_treatment, ICI, immune checkpoint inhibitor, DC50, concentration for 50% degradation, Review, ACMA, 9-amino-6-chloro-2-methoxyacridine, PD-1, programmed death receptor 1, ULD, ubiquitin-like domain, Anti-tumor, ABZI, amidobenzimidazole, 0302 clinical medicine, GMP, guanosine monophosphate, LBD, ligand-binding domain, GTP, guanosine triphosphate, PRRs, pattern recognition receptors, Interferon, cAIMP, cyclic adenosine-inosine monophosphate, Medicine, CMA, 10-carboxymethyl-9-acridanone, General Pharmacology, Toxicology and Pharmaceutics, IKK, IκB kinase, ISG, interferon stimulated gene, MinEC5×, minimum effective concentration for inducing 5-fold luciferase activity, 0303 health sciences, KD, kinase domain, dsDNA, double-stranded DNA, MG, Mangostin, ITC, isothermal titration calorimetry, Immunogenicity, PBMCs, peripheral-blood mononuclear cells, MDCK, Madin–Darby canine kidney, PROTACs, proteolysis targeting chimeras, FAA, flavone-8-acetic acid, CTD, C-terminal domain, DMXAA, 5,6-dimethylxanthenone-4-acetic acid, DSDP, dispiro diketopiperzine, STAT, signal transducer and activator of transcription, medicine.anatomical_structure, 030220 oncology & carcinogenesis, CDN, cyclic dinucleotide, QC, quinacrine, FP, fluorescence polarization, PDK1, 3-phosphoinositide-dependent protein kinase 1, Immunotherapy, Signal transduction, DCs, dendritic cells, CDA, cyclic diadenosine monophosphate (c-di-AMP), medicine.drug, Ntase, nucleotidyl transferase, ATP, adenosine triphosphate, CDG, cyclic diguanosine monophosphate (c-di-GMP), T cell, SDD, scaffold and dimerization domain, NF-κB, nuclear factor-κB, STING, stimulator of interferon genes, TNFRSF, tumor necrosis factor receptor superfamily, EM, cryo-electron microscopy, ER, endoplasmic reticulum, 03 medical and health sciences, MLK, mixed lineage kinase, Immune system, CBD, cyclic dinucleotide-binding domain, THIQCs, tetrahydroisoquinolone acetic acids, SAR, structure–activity relationship, HCQ, hydrochloroquine, ENPP1, ecto-nucleotide pyrophosphatase/phosphodiesterase, HTS, high throughput screening, 030304 developmental biology, MI, maximum induction, CXCL, chemokine (C-X-C motif) ligand, Innate immune system, PDE, phosphodiesterases, IO, immune-oncology, business.industry, IRF3, interferon regulatory factor 3, i.t., intratumoral, CTT, C-terminal tail, lcsh:RM1-950, BNBC, 6-bromo-N-(naphthalen-1-yl)benzo[d][1,3]dioxole-5-carboxamide, Chimeric antigen receptor, PPi, pyrophosphoric acid, Small molecule modulators, FDA, U.S. Food and Drug Administration, VHL, von Hippel–Lindau, lcsh:Therapeutics. Pharmacology, AMP, adenosine monophosphate, TBK1, TANK-binding kinase 1, Cancer research, cGAMP, cyclic guanosine monophosphate-adenosine monophosphate, business, cGAS, cyclic guanosine monophosphate-adenosine monophosphate synthase, CTLA-4, cytotoxic T lymphocyte associated protein 4, cGAS, STING

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c604607610f05b2d37da5b2cce00382
http://www.sciencedirect.com/science/article/pii/S2211383519316946

المؤلفون: Lupei Du, Xiaodong Shi, Yuxing Lin, Xiaojun Qin, Minyong Li, Hui Song, Xiang Li, Zheng Zhang, Gaopan Dong, Zhongxia Yu, Wei Zhao, Zhenzhen Li

المصدر: Acta Pharmaceutica Sinica B, Vol 10, Iss 9, Pp 1669-1679 (2020)
Acta Pharmaceutica Sinica. B

مصطلحات موضوعية: DMSO, dimethylsulfoxide, Ubiquitylation, 03 medical and health sciences, Degradation, 0302 clinical medicine, Ubiquitin, α1A-AR, α1A-adrenergic receptor, TEA, triethylamine, BPH, benign prostatic hyperplasia, CRBN, cereblon, General Pharmacology, Toxicology and Pharmaceutics, Receptor, α1D-AR, α1D-adrenergic receptor, GPCR, G-protein-coupled receptor, 030304 developmental biology, G protein-coupled receptor, 0303 health sciences, Prostate cancer, biology, Chemistry, Cereblon, lcsh:RM1-950, PROTACs, proteolysis targeting chimeras, hPCE, human prostate cancer epithelial, Ligand (biochemistry), Small molecule, DCM, dichloromethane, Cell biology, Ubiquitin ligase, α1A-Adrenergic receptor, lcsh:Therapeutics. Pharmacology, 030220 oncology & carcinogenesis, HPLC, high-performance liquid chromatography, α1B-AR, α1B-adrenergic receptor, biology.protein, Small-molecule PROTACs, Original Article, DMF, dimethylformamide, Target protein, α1-ARs, α1-adrenergic receptors, LUTS, lower urinary tract symptoms, THF, tetrahydrofuran

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2ee89c25ae13d3b9aa09ea20848e78
http://www.sciencedirect.com/science/article/pii/S2211383519313188

المؤلفون: Ronen Gabizon, Yair Herishanu, Nir London, Talia Kamdjou, Yamit Shorer Arbel, Anat Levin, Ben-Zion Katz, Irit Avivi, Amit Shraga, Yotam Bronstein, Chava Perry

المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Cell signaling, Chronic lymphocytic leukemia, CLL (Chronic Lymphocytic Leukemia), 01 natural sciences, 03 medical and health sciences, chemistry.chemical_compound, ibrutinib, immune system diseases, hemic and lymphatic diseases, medicine, BTK - Bruton’s tyrosine kinase, Bruton's tyrosine kinase, RC254-282, Original Research, PROTACs (proteolysis targeting chimeras), biology, 010405 organic chemistry, breakpoint cluster region, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, 0104 chemical sciences, Ubiquitin ligase, 030104 developmental biology, Oncology, chemistry, Ibrutinib, biology.protein, Cancer research, BCR (B cell receptor) signaling, Phosphorylation, Tyrosine kinase

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69908d26fc39f63720cd02ea174e18af
https://doi.org/10.3389/fonc.2021.646971

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Ding C; Research Laboratory of Medicinal Chemical Biology & Frontiers on Drug Discovery (RLMCBFDD), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Song Z; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Shen A; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Chen T; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Zhang A; Research Laboratory of Medicinal Chemical Biology & Frontiers on Drug Discovery (RLMCBFDD), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.

المصدر: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2020 Dec; Vol. 10 (12), pp. 2272-2298. Date of Electronic Publication: 2020 Mar 13.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE